04/04/2025 8:07 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2025 4:03 PM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2025 8:11 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2025 8:03 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2025 8:05 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/19/2025 7:48 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2025 3:15 PM | Sonnet BioTherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/13/2025 7:09 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2025 11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
02/02/2025 11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
01/31/2025 3:56 PM | Sonnet BioTherapeutics (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for SONN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
01/31/2025 3:57 PM | Sonnet BioTherapeutics (Filer)
| Form 424B3 | |
01/30/2025 4:25 PM | Sonnet BioTherapeutics (Filer)
| Form S-1/A | |
01/30/2025 4:25 PM | Sonnet BioTherapeutics (Filer)
| Form S-1/A | |
01/28/2025 8:10 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/21/2025 11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
01/21/2025 8:17 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/21/2025 7:30 AM | Sonnet BioTherapeutics (Filer)
| Form 424B3 | |
01/13/2025 3:34 PM | Sonnet BioTherapeutics (Filer)
| Form POS AM | |
12/23/2024 3:05 PM | Sonnet BioTherapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/17/2024 8:00 AM | Sonnet BioTherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
12/17/2024 7:50 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/10/2024 8:25 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/10/2024 8:20 AM | Sonnet BioTherapeutics (Filer)
| Form 424B5 | |
12/09/2024 7:50 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2024 8:55 PM | Cross John Harry III (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | Kenney Richard T (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | Mohan Pankaj (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | Griffith Donald J. (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | Cini John K. (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | Rao Raghu (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | Dyrness Albert D. (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | McNeill Lori (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | Dexter Susan (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 8:55 PM | Bhatt Nailesh (Reporting) Sonnet BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2024 8:20 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/26/2024 4:15 PM | Sonnet BioTherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/08/2024 7:30 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 8:22 AM | Sonnet BioTherapeutics (Filer)
| Form 424B4 | |
11/06/2024 11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
11/06/2024 8:22 AM | Sonnet BioTherapeutics (Filer)
| Form S-1/A | |
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad) A Historic Gold Announcement Is About to Rock Wall Street
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Be ready before the historic gold move. Get Garrett’s Top Four picks now. |
11/06/2024 7:48 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 8:01 AM | Sonnet BioTherapeutics (Filer)
| Form S-1/A | |
10/28/2024 8:01 AM | Sonnet BioTherapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
10/17/2024 7:50 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 7:56 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:30 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2024 7:36 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 4:15 PM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/30/2024 7:30 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 4:27 PM | Sonnet BioTherapeutics (Filer)
| Form DEF 14A | |
08/19/2024 4:28 PM | Sonnet BioTherapeutics (Filer)
| Form ARS | |
08/19/2024 7:50 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:41 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:45 AM | Sonnet BioTherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024 4:28 PM | Sonnet BioTherapeutics (Filer)
| Form PRE 14A | |
07/24/2024 7:36 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2024 11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
07/15/2024 4:05 PM | Sonnet BioTherapeutics (Filer)
| Form 424B3 | |
07/05/2024 3:06 PM | Sonnet BioTherapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/20/2024 3:49 PM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 7:15 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 6:35 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |